7/19/2019  9:59:58 PM Chg. -0.28 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
42.78USD -0.65% 679,582
Turnover: 29.26 mill.
-Bid Size: - -Ask Size: - 237.8 bill.USD 3.23% 22.51

Business description

Pfizer Inc. is a research-based, global biopharmaceutical company.
 

Management board & Supervisory board

CEO
Albert Bourla
Management board
Frank D'Amelio, Angela Hwang, Dawn Rogers, Doug Lankler, Dr. Mikael Dolsten, Dr. Rod MacKenzie, Freda C. Lewis-Hall, John Young, Lidia Fonseca, Michael Goettler, Rady Johnson, Sally Susman
Supervisory board
Ian C. Read, Dr. Scott Gottlieb, Dennis A. Ausiello, Dr. Albert Bourla, Dr. Dan R. Littman, Helen H. Hobbs, James C. Smith, James M. Kilts, Joseph J. Echevarria, Ronald E. Blaylock, Shantanu Narayen, Suzanne Nora Johnson, W. Don Cornwell
 

Company data

Name: Pfizer Inc.
Address: 235 East 42nd Street,New York, New York 10017, USA
Phone: +1-212-733-2323
Fax: -
E-mail: -
Internet: www.pfizer.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 79.09%
IPO date: -

Investor relations

Name: Chuck Triano
IR phone: +1-212-733-3901
IR Fax: -
IR e-mail: Charles.E.Triano@pfizer.com

Company calendar

CW 31 | 7/30/2019 Interim Report 2nd Quarter/6 Months
CW 36 | 9/3/2019 Dividend Payment
 

Main Shareholders

Freefloat
 
79.09%
BlackRock, Inc.
 
8.00%
The Vanguard Group, Inc.
 
7.81%
State Street Corporation
 
5.10%